Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agree!
I'm adding a few more today. The upcoming news/surge will send share price higher.
AMRR
Great golf tournament! Will be watching Sunday afternoon.
Noam Chomsky, at age 93, still telling it like it is
December 07, 2021
Linguist and political activist Noam Chomsky was born in Philadelphia on this day in 1928.
In his early academic career, Chomsky was best known for his work Syntactic Structures, a theory of "generative grammar" that transformed linguistics from an obscure discipline into a major social science. Outside of academia, Chomsky is better known as a political activist—a role that he vigorously assumed as an early and outspoken critic and protester of the Vietnam War.
In recognition of Chomsky's 93rd birthday, we checked into what he has been up to during the past year. A quick internet survey yielded stunning results. During his 93rd year, he gave over 50 audio and video interviews on topics ranging from Afghanistan, climate devastation, the pandemic, Julian Assange, Indian farmers, and, of course, the long-standing theme of American military imperialism. His published articles in 2021 include, with Vijay Prashad, "There are 3 major threats to life on Earth that we must address in 2021" (nuclear annihilation, climate catastrophe, and neoliberal destruction of the social contract). Then there are three new books in 2021: The Precipice, Consequences of Capitalism, and Chomsky for Activists. His work, with Robert Pollin and C.J. Polychroniou, Climate Crisis and the Global Green New Deal, came out in late 2020.
It's only a $5000. suite @ tournament:
TITLE SPONSOR
PREMIER PARTNERS
NELSON SUITES
Axxess
Bank of America
Centurion American Development Group
CMI Tax Consultants
Craig International – District 121
Horizon Capital Partners LLC- Moss & Associates
Encore Wire
First United Bank
Healthcare Highways
Highlands Residential Mortgage
Independent Financial
McKinney Economic Development Corporation
Multiband Global
RPMx
SRS Distribution
WEISKOPF SUITES
Capital Title Commercial
JLL – Lockton Companies
Raytheon Intelligence & Space
Tailwater Capital
SKYBOXES - 17 GREEN
Avison Young
CBRE
Choctaw Casinos & Resorts
Emerson
Haynes Boone
KPMG
PNC Bank
SKYBOXES - 17 TEE
Diamond Realty Investments, INC.
Frost Brown Todd- Comerica
Hill Wilkinson- FMG – Corrigan – Ace Décor-Calhar
JPMorgan Chase
McKinney Economic Development Corporation
Norton Rose Fulbright
Sealy & Company
SKYBOXES - 16 GREEN
Amazon Web Services
Bank of Texas- Chicago Title
Big Green Egg
Capital One Commercial Banking
CDW
Chisum Sports & Hospitality
Fortinet
Orix Corporation USA Group
Salesmanship Club Class of 2021
Stonebriar Commercial Finance
Western Extrusions CORP.
SIGNATURE SUITES
Aimbridge Hospitality
Alamo Equity, LLC
Alpha Construction – Tactical Demolition
American Airlines & Mastercard
Baker Tilly
Benchmark/Bank-Title-Wealth-PF/KDC
Bloomfield – ASWM – CHC – Mission
Broadwing Aviation – Egan Nelson – Flatland Mineral – Reeder Capital
Chicago Title National Commercial Services
City of McKinney
Colliers
Copart
Costar Group
Crestcars.com – Maridoe Golf Club
Crestcars.com – Top Notch
Crossland Construction
Crow Holdings Capital
Dallas Cowboys – Blue Star Land – Superscapes
Eagle Oil – Carrollton/Sterling Family Partners
Eastdil Secured
Egrets
Evolution Spine/Evo
Frontier Waste Solutions/PWC
Fusion Waste & Recycling
Greystar – Thackery – Bracewell
Higginbotham Insurance and Financial Services
Highlander Partners – Hillwood – HL&S LLC
IBM
IMA, NDBT, RHR Oil & Gas
Jackson Walker LLP
Joshmoodyloans.com – Mayben Realty – Hudson Title
Kaizen D.P. – LAFP – Parscale Group – Whiting – Turner
Kensington Vanguard Title Co – AM National Bank
McKinney Buick GMC – Leviate Air Group
McKinney Corporate Center Craig Ranch – KDC
Michelob Ultra
Mogul Wealth – Talent Corps
Oncor
Osburn COntractors
Owens Corning
Pinnacle – Centapro Painters – RV Retailer
Redden Concrete Inc.
RGT Wealth Advisors – Fannin Tree Farm
Rminds inc. – N9 Capital Partners, LLC
Salesmanship Club Class of 2020
Salesmanship Club Class of 2021
Sequel Holdings
Shackelford, Bowen, McKinley, & Norton LLP
SOI Group, INC
STIFEL
Sunflower Bank – The Rhodes Group – BMO – WRA
Velocis- TAC – Potter Concrete
Wells Fargo
Westwood Wealth Management – Platform Ventures
Winstead PC
XSell Technologies
CREEKSIDE BOXES
BBG – Ashton Commerical Construction
Ben E. Keith Foods
Benchmark – Exeter – Systemware – Turcotte
Camwest
Constellation Brands
Craig International SIrius Plumbing & AC
Cushman & Wakefield
Cyrberone
Denjen Enterprises, INC. All-Spec Sales, INC.
ENT, Texas – Valiant ANesthesia Associates
Flexential
Frost Bank
Independence Title
Napco Bag and Film
Pacesetter Homes
Premier Trailer – Hyundai – Maxon – TK
Salesmanship Club of 2018
SFMG Wealth Advisors
Sherwin-Williams
Technologent
Texas Capital Bank
True North Advisors + Dexter & Company
Walker & Dunlop
CHAMPIONS CLUB
CHOCTAW CLUB
THE ULTRA CLUB
DONATIONS
DISPLAY BOOTHS
VIDEO BOARDS
HEALTHCARE HIGHWAYS PRO-AM
CELEBRITY-AM
MONDAY PRO-AM
OPERATION APPRECIATION PRESENTED BY MOVE IT STORAGE
CORPORATE CHALLENGE PRESENTED BY SEWELL AUTOMOTIVE COMPANIES
LMAO! > Is that in reference to the Mullen car seats?
You guys better cover your assssssssssss
Washington is one big swamp!
Biden is so clueless! Plus he blames Putin & Trump on our petroleum issues.
Absolutely no leadership in this Democrat administration!
© Copyright 2022
Follow InvestorsHub on Twitter!
BBIO > 5.81
So many retailers abandoning the use of cryptocurrency. Way too disruptive and volatile for businesses running on tight margins.
BBIO up 8% @ 5.61 > huge deal with Bristol Myers.
BBIO > BridgeBio Inks BBP-398 License With Bristol Myers .
7:52 am ET May 12, 2022 (Dow Jones) Print
By Colin Kellaher
BridgeBio Pharma Inc. on Thursday said it signed an exclusive license agreement potentially worth more than $900 million with Bristol Myers Squibb Co. to develop and commercialize BridgeBio's BBP-398 small-molecular inhibitor in oncology.
BridgeBio, a Palo Alto, Calif., biopharmaceutical company, said it will receive an upfront payment of $90 million and will be eligible for up to $815 million in development, regulatory and sales milestone payments, along with royalties on sales.
BridgeBio said the new agreement expands a 2021 agreement with Bristol Myers to evaluate the combination of BBP-398 with the New York biopharmaceutical company's blockbuster cancer drug Opdivo in patients with advanced solid tumors with KRAS mutations.
BridgeBio said it will continue to lead its ongoing Phase 1 monotherapy and combination therapy trials, while Bristol Myers leads and funds all other development and commercial activities.
BridgeBio earlier this year said it would evaluate BBP-398 in combination with Amgen Inc.'s cancer drug Lumakras in patients with advanced solid tumors with the KRAS G12C mutation.
Shares of BridgeBio, which closed Wednesday at $5.21, rose 9% in premarket trading Thursday.
Write to Colin Kellaher at colin.kellaher@wsj.com
LET'S GO BBIO > $$$$$
How can bitcoin survive in a sea of 1000's of cryptocurrencies worldwide!
8.81 > How can bitcoin survive in a sea of 1000's of cryptocurrencies worldwide!
MARA
BBIO > $905 M > To Receive Up To $905M From Bristol Myers Squibb In Agreement
7:33 am ET May 12, 2022 (Benzinga) Print
- BridgeBio is eligible to receive up to $905 million, including an upfront payment of $90 million, and up to $815 million in additional milestone payments and royalties
-SHP2 inhibitor deal expands earlier agreement between BridgeBio and Bristol Myers Squibb to study BBP-398 in combination with OPDIVO® (nivolumab) in advanced solid tumors with KRAS mutations
- BridgeBio will continue to lead its three current Phase 1 monotherapy and BBP-398 combination therapy trials with additional support from Bristol Myers Squibb; future clinical trials will be performed and funded by Bristol Myers Squibb
BridgeBio Eligible To Receive Up To $905M From Bristol Myers Squibb In Agreement
7:33 am ET May 12, 2022 (Benzinga) Print
- BridgeBio is eligible to receive up to $905 million, including an upfront payment of $90 million, and up to $815 million in additional milestone payments and royalties
-SHP2 inhibitor deal expands earlier agreement between BridgeBio and Bristol Myers Squibb to study BBP-398 in combination with OPDIVO® (nivolumab) in advanced solid tumors with KRAS mutations
- BridgeBio will continue to lead its three current Phase 1 monotherapy and BBP-398 combination therapy trials with additional support from Bristol Myers Squibb; future clinical trials will be performed and funded by Bristol Myers Squibb
7.10 > early hod.
"Our need for additional financing" > Blue Water Vaccines Inc. to Present at H.C. Wainwright Global Investment Conference
8:30 am ET May 12, 2022 (Globe Newswire) Print
EQNX::TICKER_START (NASDAQ:BWV), EQNX::TICKER_END Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company") a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that Erin Henderson, Chief Business Officer of Blue Water Vaccines, will present at the H.C. Wainwright Global Investment Conference. The presentation will be available for on-demand webcast viewing starting on Wednesday, May 25, 2022, at 9:00am EDT.
Session details are as follows
Date: Wednesday, May 25, 2022
Time: 9:00am Eastern Daylight Time (EDT)
Title: Blue Water Vaccines Company Presentation
BWV Participant: Erin Henderson, Chief Business Officer
Webcast Link: https://journey.ct.events/view/1e8775a5-ce07-4395-867a-0cadcc5664e5
BWV's management will be available during the conference for one-on-one meetings. Interested parties may request a one-on-one meeting at investors@bluewatervaccines.com or contact BWV at (513) 620-4101.
Biden is so clueless! Plus he blames Putin & Trump on our petroleum issues.
Absolutely no leadership in this Democrat administration!
Are car seats available for Mullen? Supply chain issues on upholstery !
"look forward to exploring the possibility of developing this preliminary research into a new vaccine platform" > This translates into long and winding road. Then comes FDA clinical trials > PHASE I > then Phase II > then Phase III >>>> And finally FDA Approval.
BWV
I would love to know which mine Musk is looking at.
TSLA
Totally dependent on Bitcoin pricing.
I was thinking of buying shares in AH. I'll have to do more research.
Dropping huge! 5.56 × 5.60 > Best of luck pal!
BWV > Blue Water Vaccines Shares Halted On Circuit Breaker .
.10 x 90.00 > HALT !!!!!!!!!!!!!!
>>>>> 3.26 to 90.90 <<<<< BWV
> Provisional patents have been recently filed for both H3 and influenza B antigens by the Company's licensors and will be used in combination with previously identified H1 epitopes to form the basis for the Company's universal influenza vaccine candidate, BWV-101:
"The large seasonal burden of influenza warrants the development of improved vaccines," said Joseph Hernandez, Chief Executive Officer of Blue Water Vaccines. "This data for H3N2 and influenza B epitopes supports our commitment to develop a vaccine that provides broad protection against all strains and eliminating the need for annual immunization. We are excited to continue our collaboration with The University of Oxford and move forward with this research supporting one of our lead vaccine candidates."
BAOS gangbusters! Up 36% @ .77
Massive dilution / FORD selling their shares taking MULN down to .50 in upcoming sessions.
Just hit .97 cents!!!!!
83.45 high down to 11.54 ( last 52 weeks ).
>>>>> NIGHTMARA ! <<<<<
BTTX > heavy volune! Tutes accumulating!
$weet ! Going gangbusters!
LOGC
Looking @ run to $40.00+ in next couple sessions.
FRGE
Agree!
I have made over $450K in several OTC equities. Running multi-dollars is one of the common denominators. SYSX is next!
Current Revenue Per Employee > $575,000. > MarketWatch > One of many positive catalysts!
SYSX